nodes	percent_of_prediction	percent_of_DWPC	metapath
Vinorelbine—CYP2D6—Niacin—atherosclerosis	0.0672	0.108	CbGbCtD
Vinorelbine—ABCB1—Ezetimibe—atherosclerosis	0.0606	0.0972	CbGbCtD
Vinorelbine—ABCB1—Simvastatin—atherosclerosis	0.0563	0.0903	CbGbCtD
Vinorelbine—ABCB1—Pravastatin—atherosclerosis	0.0551	0.0884	CbGbCtD
Vinorelbine—ABCB1—Lovastatin—atherosclerosis	0.0551	0.0884	CbGbCtD
Vinorelbine—CYP2D6—Simvastatin—atherosclerosis	0.0531	0.0851	CbGbCtD
Vinorelbine—CYP2D6—Lovastatin—atherosclerosis	0.0519	0.0833	CbGbCtD
Vinorelbine—CYP2D6—Pravastatin—atherosclerosis	0.0519	0.0833	CbGbCtD
Vinorelbine—CYP3A4—Ezetimibe—atherosclerosis	0.0363	0.0582	CbGbCtD
Vinorelbine—CYP3A4—Rosuvastatin—atherosclerosis	0.0363	0.0582	CbGbCtD
Vinorelbine—CYP3A4—Simvastatin—atherosclerosis	0.0338	0.0541	CbGbCtD
Vinorelbine—CYP3A4—Lovastatin—atherosclerosis	0.033	0.053	CbGbCtD
Vinorelbine—CYP3A4—Pravastatin—atherosclerosis	0.033	0.053	CbGbCtD
Vinorelbine—TUBB6—Pimozide—Ezetimibe—atherosclerosis	0.00242	0.288	CbGdCrCtD
Vinorelbine—TUBB6—Fluvastatin—Rosuvastatin—atherosclerosis	0.00206	0.245	CbGdCrCtD
Vinorelbine—TUBB6—Simvastatin—Pravastatin—atherosclerosis	0.00197	0.234	CbGdCrCtD
Vinorelbine—TUBB6—Simvastatin—Lovastatin—atherosclerosis	0.00197	0.234	CbGdCrCtD
Vinorelbine—TUBB3—connective tissue—atherosclerosis	0.00131	0.103	CbGeAlD
Vinorelbine—Infestation—Ezetimibe—atherosclerosis	0.0012	0.00468	CcSEcCtD
Vinorelbine—Neuropathy peripheral—Lovastatin—atherosclerosis	0.00119	0.00468	CcSEcCtD
Vinorelbine—Muscular weakness—Pravastatin—atherosclerosis	0.00118	0.00462	CcSEcCtD
Vinorelbine—Dysphagia—Niacin—atherosclerosis	0.00117	0.0046	CcSEcCtD
Vinorelbine—Neuropathy peripheral—Ezetimibe—atherosclerosis	0.00117	0.00459	CcSEcCtD
Vinorelbine—Arrhythmia—Rosuvastatin—atherosclerosis	0.00115	0.00451	CcSEcCtD
Vinorelbine—Angina pectoris—Niacin—atherosclerosis	0.00114	0.00448	CcSEcCtD
Vinorelbine—Pancreatitis—Pravastatin—atherosclerosis	0.00113	0.00444	CcSEcCtD
Vinorelbine—Hepatobiliary disease—Ezetimibe—atherosclerosis	0.00113	0.00443	CcSEcCtD
Vinorelbine—Angina pectoris—Pravastatin—atherosclerosis	0.00113	0.00441	CcSEcCtD
Vinorelbine—Neuropathy peripheral—Simvastatin—atherosclerosis	0.00112	0.00437	CcSEcCtD
Vinorelbine—Connective tissue disorder—Ezetimibe—atherosclerosis	0.00105	0.00413	CcSEcCtD
Vinorelbine—Weight decreased—Pravastatin—atherosclerosis	0.00105	0.00409	CcSEcCtD
Vinorelbine—Angioedema—Rosuvastatin—atherosclerosis	0.00103	0.00402	CcSEcCtD
Vinorelbine—Stomatitis—Niacin—atherosclerosis	0.00102	0.00399	CcSEcCtD
Vinorelbine—Acute coronary syndrome—Pravastatin—atherosclerosis	0.00102	0.00398	CcSEcCtD
Vinorelbine—Flushing—Lovastatin—atherosclerosis	0.00102	0.00397	CcSEcCtD
Vinorelbine—Myocardial infarction—Pravastatin—atherosclerosis	0.00101	0.00395	CcSEcCtD
Vinorelbine—Neuropathy peripheral—Pravastatin—atherosclerosis	0.00101	0.00395	CcSEcCtD
Vinorelbine—Flushing—Ezetimibe—atherosclerosis	0.000996	0.0039	CcSEcCtD
Vinorelbine—TUBB1—adipose tissue—atherosclerosis	0.000986	0.0771	CbGeAlD
Vinorelbine—Cough—Rosuvastatin—atherosclerosis	0.000981	0.00384	CcSEcCtD
Vinorelbine—Angiopathy—Ezetimibe—atherosclerosis	0.000974	0.00381	CcSEcCtD
Vinorelbine—Immune system disorder—Ezetimibe—atherosclerosis	0.000969	0.00379	CcSEcCtD
Vinorelbine—Mediastinal disorder—Ezetimibe—atherosclerosis	0.000967	0.00379	CcSEcCtD
Vinorelbine—Alopecia—Lovastatin—atherosclerosis	0.000967	0.00378	CcSEcCtD
Vinorelbine—Arthralgia—Rosuvastatin—atherosclerosis	0.000957	0.00375	CcSEcCtD
Vinorelbine—Myalgia—Rosuvastatin—atherosclerosis	0.000957	0.00375	CcSEcCtD
Vinorelbine—Flushing—Simvastatin—atherosclerosis	0.00095	0.00372	CcSEcCtD
Vinorelbine—Alopecia—Ezetimibe—atherosclerosis	0.000948	0.00371	CcSEcCtD
Vinorelbine—Hypoaesthesia—Niacin—atherosclerosis	0.000935	0.00366	CcSEcCtD
Vinorelbine—Malnutrition—Ezetimibe—atherosclerosis	0.000934	0.00366	CcSEcCtD
Vinorelbine—Erythema—Ezetimibe—atherosclerosis	0.000934	0.00366	CcSEcCtD
Vinorelbine—Back pain—Lovastatin—atherosclerosis	0.000921	0.00361	CcSEcCtD
Vinorelbine—Hypoaesthesia—Pravastatin—atherosclerosis	0.00092	0.0036	CcSEcCtD
Vinorelbine—Infection—Rosuvastatin—atherosclerosis	0.000911	0.00357	CcSEcCtD
Vinorelbine—Alopecia—Simvastatin—atherosclerosis	0.000904	0.00354	CcSEcCtD
Vinorelbine—Back pain—Ezetimibe—atherosclerosis	0.000904	0.00354	CcSEcCtD
Vinorelbine—Nervous system disorder—Rosuvastatin—atherosclerosis	0.000899	0.00352	CcSEcCtD
Vinorelbine—Thrombocytopenia—Rosuvastatin—atherosclerosis	0.000898	0.00352	CcSEcCtD
Vinorelbine—Erythema—Simvastatin—atherosclerosis	0.000891	0.00349	CcSEcCtD
Vinorelbine—Ill-defined disorder—Lovastatin—atherosclerosis	0.000884	0.00346	CcSEcCtD
Vinorelbine—Flushing—Niacin—atherosclerosis	0.000872	0.00341	CcSEcCtD
Vinorelbine—Angioedema—Lovastatin—atherosclerosis	0.00087	0.00341	CcSEcCtD
Vinorelbine—Ill-defined disorder—Ezetimibe—atherosclerosis	0.000867	0.00339	CcSEcCtD
Vinorelbine—Anaemia—Ezetimibe—atherosclerosis	0.000863	0.00338	CcSEcCtD
Vinorelbine—Malaise—Lovastatin—atherosclerosis	0.000859	0.00336	CcSEcCtD
Vinorelbine—Flushing—Pravastatin—atherosclerosis	0.000859	0.00336	CcSEcCtD
Vinorelbine—Cardiac disorder—Pravastatin—atherosclerosis	0.000859	0.00336	CcSEcCtD
Vinorelbine—Vertigo—Lovastatin—atherosclerosis	0.000856	0.00335	CcSEcCtD
Vinorelbine—Angioedema—Ezetimibe—atherosclerosis	0.000853	0.00334	CcSEcCtD
Vinorelbine—Angiopathy—Niacin—atherosclerosis	0.000852	0.00334	CcSEcCtD
Vinorelbine—Leukopenia—Lovastatin—atherosclerosis	0.000852	0.00334	CcSEcCtD
Vinorelbine—Malaise—Ezetimibe—atherosclerosis	0.000842	0.0033	CcSEcCtD
Vinorelbine—Arrhythmia—Niacin—atherosclerosis	0.000839	0.00329	CcSEcCtD
Vinorelbine—Musculoskeletal discomfort—Rosuvastatin—atherosclerosis	0.000836	0.00327	CcSEcCtD
Vinorelbine—Alopecia—Niacin—atherosclerosis	0.00083	0.00325	CcSEcCtD
Vinorelbine—Ill-defined disorder—Simvastatin—atherosclerosis	0.000826	0.00324	CcSEcCtD
Vinorelbine—Arrhythmia—Pravastatin—atherosclerosis	0.000826	0.00324	CcSEcCtD
Vinorelbine—Palpitations—Ezetimibe—atherosclerosis	0.000825	0.00323	CcSEcCtD
Vinorelbine—Paraesthesia—Rosuvastatin—atherosclerosis	0.000824	0.00322	CcSEcCtD
Vinorelbine—Anaemia—Simvastatin—atherosclerosis	0.000823	0.00322	CcSEcCtD
Vinorelbine—Malnutrition—Niacin—atherosclerosis	0.000818	0.0032	CcSEcCtD
Vinorelbine—Erythema—Niacin—atherosclerosis	0.000818	0.0032	CcSEcCtD
Vinorelbine—Alopecia—Pravastatin—atherosclerosis	0.000817	0.0032	CcSEcCtD
Vinorelbine—Cough—Ezetimibe—atherosclerosis	0.000815	0.00319	CcSEcCtD
Vinorelbine—Angioedema—Simvastatin—atherosclerosis	0.000814	0.00319	CcSEcCtD
Vinorelbine—Myalgia—Lovastatin—atherosclerosis	0.000811	0.00317	CcSEcCtD
Vinorelbine—Chest pain—Lovastatin—atherosclerosis	0.000811	0.00317	CcSEcCtD
Vinorelbine—Arthralgia—Lovastatin—atherosclerosis	0.000811	0.00317	CcSEcCtD
Vinorelbine—Hypertension—Ezetimibe—atherosclerosis	0.000806	0.00316	CcSEcCtD
Vinorelbine—Malaise—Simvastatin—atherosclerosis	0.000803	0.00314	CcSEcCtD
Vinorelbine—Discomfort—Lovastatin—atherosclerosis	0.000801	0.00314	CcSEcCtD
Vinorelbine—Vertigo—Simvastatin—atherosclerosis	0.0008	0.00313	CcSEcCtD
Vinorelbine—TUBB4A—connective tissue—atherosclerosis	0.0008	0.0625	CbGeAlD
Vinorelbine—Leukopenia—Simvastatin—atherosclerosis	0.000797	0.00312	CcSEcCtD
Vinorelbine—Arthralgia—Ezetimibe—atherosclerosis	0.000795	0.00311	CcSEcCtD
Vinorelbine—Myalgia—Ezetimibe—atherosclerosis	0.000795	0.00311	CcSEcCtD
Vinorelbine—Chest pain—Ezetimibe—atherosclerosis	0.000795	0.00311	CcSEcCtD
Vinorelbine—Unspecified disorder of skin and subcutaneous tissue—Ezetimibe—atherosclerosis	0.00079	0.00309	CcSEcCtD
Vinorelbine—Discomfort—Ezetimibe—atherosclerosis	0.000786	0.00308	CcSEcCtD
Vinorelbine—Constipation—Rosuvastatin—atherosclerosis	0.000784	0.00307	CcSEcCtD
Vinorelbine—Pain—Rosuvastatin—atherosclerosis	0.000784	0.00307	CcSEcCtD
Vinorelbine—Anaphylactic shock—Lovastatin—atherosclerosis	0.000777	0.00304	CcSEcCtD
Vinorelbine—TUBB2B—connective tissue—atherosclerosis	0.000773	0.0604	CbGeAlD
Vinorelbine—Infection—Lovastatin—atherosclerosis	0.000772	0.00302	CcSEcCtD
Vinorelbine—Anaphylactic shock—Ezetimibe—atherosclerosis	0.000762	0.00298	CcSEcCtD
Vinorelbine—Thrombocytopenia—Lovastatin—atherosclerosis	0.000761	0.00298	CcSEcCtD
Vinorelbine—Chest pain—Simvastatin—atherosclerosis	0.000758	0.00297	CcSEcCtD
Vinorelbine—Myalgia—Simvastatin—atherosclerosis	0.000758	0.00297	CcSEcCtD
Vinorelbine—Arthralgia—Simvastatin—atherosclerosis	0.000758	0.00297	CcSEcCtD
Vinorelbine—Infection—Ezetimibe—atherosclerosis	0.000757	0.00296	CcSEcCtD
Vinorelbine—Feeling abnormal—Rosuvastatin—atherosclerosis	0.000756	0.00296	CcSEcCtD
Vinorelbine—Gastrointestinal pain—Rosuvastatin—atherosclerosis	0.00075	0.00294	CcSEcCtD
Vinorelbine—Discomfort—Simvastatin—atherosclerosis	0.000749	0.00293	CcSEcCtD
Vinorelbine—Nervous system disorder—Ezetimibe—atherosclerosis	0.000748	0.00293	CcSEcCtD
Vinorelbine—Angioedema—Niacin—atherosclerosis	0.000747	0.00293	CcSEcCtD
Vinorelbine—Ill-defined disorder—Pravastatin—atherosclerosis	0.000747	0.00293	CcSEcCtD
Vinorelbine—Thrombocytopenia—Ezetimibe—atherosclerosis	0.000746	0.00292	CcSEcCtD
Vinorelbine—Anaemia—Pravastatin—atherosclerosis	0.000744	0.00291	CcSEcCtD
Vinorelbine—Anorexia—Lovastatin—atherosclerosis	0.000741	0.0029	CcSEcCtD
Vinorelbine—Skin disorder—Ezetimibe—atherosclerosis	0.00074	0.0029	CcSEcCtD
Vinorelbine—Angioedema—Pravastatin—atherosclerosis	0.000736	0.00288	CcSEcCtD
Vinorelbine—Vertigo—Niacin—atherosclerosis	0.000735	0.00288	CcSEcCtD
Vinorelbine—Leukopenia—Niacin—atherosclerosis	0.000732	0.00287	CcSEcCtD
Vinorelbine—Urticaria—Rosuvastatin—atherosclerosis	0.000729	0.00285	CcSEcCtD
Vinorelbine—TUBB2A—connective tissue—atherosclerosis	0.000728	0.0569	CbGeAlD
Vinorelbine—Anaphylactic shock—Simvastatin—atherosclerosis	0.000727	0.00285	CcSEcCtD
Vinorelbine—Malaise—Pravastatin—atherosclerosis	0.000726	0.00284	CcSEcCtD
Vinorelbine—Abdominal pain—Rosuvastatin—atherosclerosis	0.000725	0.00284	CcSEcCtD
Vinorelbine—Vertigo—Pravastatin—atherosclerosis	0.000724	0.00283	CcSEcCtD
Vinorelbine—Palpitations—Niacin—atherosclerosis	0.000723	0.00283	CcSEcCtD
Vinorelbine—Infection—Simvastatin—atherosclerosis	0.000722	0.00283	CcSEcCtD
Vinorelbine—Leukopenia—Pravastatin—atherosclerosis	0.000721	0.00282	CcSEcCtD
Vinorelbine—Cough—Niacin—atherosclerosis	0.000714	0.00279	CcSEcCtD
Vinorelbine—Thrombocytopenia—Simvastatin—atherosclerosis	0.000712	0.00279	CcSEcCtD
Vinorelbine—Musculoskeletal discomfort—Lovastatin—atherosclerosis	0.000708	0.00277	CcSEcCtD
Vinorelbine—Cough—Pravastatin—atherosclerosis	0.000703	0.00275	CcSEcCtD
Vinorelbine—Paraesthesia—Lovastatin—atherosclerosis	0.000698	0.00273	CcSEcCtD
Vinorelbine—Arthralgia—Niacin—atherosclerosis	0.000696	0.00273	CcSEcCtD
Vinorelbine—Myalgia—Niacin—atherosclerosis	0.000696	0.00273	CcSEcCtD
Vinorelbine—TUBB4A—cardiovascular system—atherosclerosis	0.000696	0.0544	CbGeAlD
Vinorelbine—Hypertension—Pravastatin—atherosclerosis	0.000695	0.00272	CcSEcCtD
Vinorelbine—Musculoskeletal discomfort—Ezetimibe—atherosclerosis	0.000695	0.00272	CcSEcCtD
Vinorelbine—Anorexia—Simvastatin—atherosclerosis	0.000693	0.00271	CcSEcCtD
Vinorelbine—Dyspnoea—Lovastatin—atherosclerosis	0.000693	0.00271	CcSEcCtD
Vinorelbine—Unspecified disorder of skin and subcutaneous tissue—Niacin—atherosclerosis	0.000692	0.00271	CcSEcCtD
Vinorelbine—Myalgia—Pravastatin—atherosclerosis	0.000686	0.00268	CcSEcCtD
Vinorelbine—Arthralgia—Pravastatin—atherosclerosis	0.000686	0.00268	CcSEcCtD
Vinorelbine—Chest pain—Pravastatin—atherosclerosis	0.000686	0.00268	CcSEcCtD
Vinorelbine—Paraesthesia—Ezetimibe—atherosclerosis	0.000685	0.00268	CcSEcCtD
Vinorelbine—Dyspnoea—Ezetimibe—atherosclerosis	0.00068	0.00266	CcSEcCtD
Vinorelbine—Discomfort—Pravastatin—atherosclerosis	0.000677	0.00265	CcSEcCtD
Vinorelbine—Hypersensitivity—Rosuvastatin—atherosclerosis	0.000676	0.00265	CcSEcCtD
Vinorelbine—Decreased appetite—Lovastatin—atherosclerosis	0.000676	0.00265	CcSEcCtD
Vinorelbine—Fatigue—Lovastatin—atherosclerosis	0.00067	0.00262	CcSEcCtD
Vinorelbine—Anaphylactic shock—Niacin—atherosclerosis	0.000668	0.00261	CcSEcCtD
Vinorelbine—Constipation—Lovastatin—atherosclerosis	0.000665	0.0026	CcSEcCtD
Vinorelbine—Pain—Lovastatin—atherosclerosis	0.000665	0.0026	CcSEcCtD
Vinorelbine—Decreased appetite—Ezetimibe—atherosclerosis	0.000663	0.00259	CcSEcCtD
Vinorelbine—Musculoskeletal discomfort—Simvastatin—atherosclerosis	0.000662	0.00259	CcSEcCtD
Vinorelbine—Gastrointestinal disorder—Ezetimibe—atherosclerosis	0.000658	0.00258	CcSEcCtD
Vinorelbine—Asthenia—Rosuvastatin—atherosclerosis	0.000658	0.00258	CcSEcCtD
Vinorelbine—Anaphylactic shock—Pravastatin—atherosclerosis	0.000657	0.00257	CcSEcCtD
Vinorelbine—Fatigue—Ezetimibe—atherosclerosis	0.000657	0.00257	CcSEcCtD
Vinorelbine—Infection—Pravastatin—atherosclerosis	0.000653	0.00256	CcSEcCtD
Vinorelbine—Paraesthesia—Simvastatin—atherosclerosis	0.000653	0.00256	CcSEcCtD
Vinorelbine—Constipation—Ezetimibe—atherosclerosis	0.000652	0.00255	CcSEcCtD
Vinorelbine—Pain—Ezetimibe—atherosclerosis	0.000652	0.00255	CcSEcCtD
Vinorelbine—Tachycardia—Niacin—atherosclerosis	0.000651	0.00255	CcSEcCtD
Vinorelbine—Pruritus—Rosuvastatin—atherosclerosis	0.000649	0.00254	CcSEcCtD
Vinorelbine—Skin disorder—Niacin—atherosclerosis	0.000648	0.00254	CcSEcCtD
Vinorelbine—Dyspnoea—Simvastatin—atherosclerosis	0.000648	0.00254	CcSEcCtD
Vinorelbine—Thrombocytopenia—Pravastatin—atherosclerosis	0.000644	0.00252	CcSEcCtD
Vinorelbine—Feeling abnormal—Lovastatin—atherosclerosis	0.00064	0.00251	CcSEcCtD
Vinorelbine—Anorexia—Niacin—atherosclerosis	0.000636	0.00249	CcSEcCtD
Vinorelbine—Gastrointestinal pain—Lovastatin—atherosclerosis	0.000636	0.00249	CcSEcCtD
Vinorelbine—Decreased appetite—Simvastatin—atherosclerosis	0.000632	0.00247	CcSEcCtD
Vinorelbine—Feeling abnormal—Ezetimibe—atherosclerosis	0.000628	0.00246	CcSEcCtD
Vinorelbine—Gastrointestinal disorder—Simvastatin—atherosclerosis	0.000628	0.00246	CcSEcCtD
Vinorelbine—Diarrhoea—Rosuvastatin—atherosclerosis	0.000628	0.00246	CcSEcCtD
Vinorelbine—Fatigue—Simvastatin—atherosclerosis	0.000627	0.00245	CcSEcCtD
Vinorelbine—Anorexia—Pravastatin—atherosclerosis	0.000627	0.00245	CcSEcCtD
Vinorelbine—TUBB6—cardiovascular system—atherosclerosis	0.000625	0.0488	CbGeAlD
Vinorelbine—TUBB4B—connective tissue—atherosclerosis	0.000624	0.0488	CbGeAlD
Vinorelbine—Hypotension—Niacin—atherosclerosis	0.000624	0.00244	CcSEcCtD
Vinorelbine—Gastrointestinal pain—Ezetimibe—atherosclerosis	0.000623	0.00244	CcSEcCtD
Vinorelbine—Pain—Simvastatin—atherosclerosis	0.000622	0.00243	CcSEcCtD
Vinorelbine—Constipation—Simvastatin—atherosclerosis	0.000622	0.00243	CcSEcCtD
Vinorelbine—Urticaria—Lovastatin—atherosclerosis	0.000617	0.00242	CcSEcCtD
Vinorelbine—Abdominal pain—Lovastatin—atherosclerosis	0.000614	0.00241	CcSEcCtD
Vinorelbine—Body temperature increased—Lovastatin—atherosclerosis	0.000614	0.00241	CcSEcCtD
Vinorelbine—Musculoskeletal discomfort—Niacin—atherosclerosis	0.000608	0.00238	CcSEcCtD
Vinorelbine—Dizziness—Rosuvastatin—atherosclerosis	0.000606	0.00237	CcSEcCtD
Vinorelbine—Urticaria—Ezetimibe—atherosclerosis	0.000606	0.00237	CcSEcCtD
Vinorelbine—Body temperature increased—Ezetimibe—atherosclerosis	0.000603	0.00236	CcSEcCtD
Vinorelbine—Abdominal pain—Ezetimibe—atherosclerosis	0.000603	0.00236	CcSEcCtD
Vinorelbine—Paraesthesia—Niacin—atherosclerosis	0.000599	0.00235	CcSEcCtD
Vinorelbine—Feeling abnormal—Simvastatin—atherosclerosis	0.000599	0.00235	CcSEcCtD
Vinorelbine—Musculoskeletal discomfort—Pravastatin—atherosclerosis	0.000599	0.00234	CcSEcCtD
Vinorelbine—Dyspnoea—Niacin—atherosclerosis	0.000595	0.00233	CcSEcCtD
Vinorelbine—Gastrointestinal pain—Simvastatin—atherosclerosis	0.000594	0.00233	CcSEcCtD
Vinorelbine—TUBB2B—adipose tissue—atherosclerosis	0.000593	0.0464	CbGeAlD
Vinorelbine—Paraesthesia—Pravastatin—atherosclerosis	0.00059	0.00231	CcSEcCtD
Vinorelbine—Dyspnoea—Pravastatin—atherosclerosis	0.000586	0.00229	CcSEcCtD
Vinorelbine—Decreased appetite—Niacin—atherosclerosis	0.00058	0.00227	CcSEcCtD
Vinorelbine—Rash—Rosuvastatin—atherosclerosis	0.000578	0.00226	CcSEcCtD
Vinorelbine—Dermatitis—Rosuvastatin—atherosclerosis	0.000578	0.00226	CcSEcCtD
Vinorelbine—Urticaria—Simvastatin—atherosclerosis	0.000578	0.00226	CcSEcCtD
Vinorelbine—Gastrointestinal disorder—Niacin—atherosclerosis	0.000576	0.00226	CcSEcCtD
Vinorelbine—Body temperature increased—Simvastatin—atherosclerosis	0.000575	0.00225	CcSEcCtD
Vinorelbine—Abdominal pain—Simvastatin—atherosclerosis	0.000575	0.00225	CcSEcCtD
Vinorelbine—Headache—Rosuvastatin—atherosclerosis	0.000575	0.00225	CcSEcCtD
Vinorelbine—Hypersensitivity—Lovastatin—atherosclerosis	0.000573	0.00224	CcSEcCtD
Vinorelbine—Decreased appetite—Pravastatin—atherosclerosis	0.000571	0.00224	CcSEcCtD
Vinorelbine—Pain—Niacin—atherosclerosis	0.000571	0.00223	CcSEcCtD
Vinorelbine—Fatigue—Pravastatin—atherosclerosis	0.000567	0.00222	CcSEcCtD
Vinorelbine—Pain—Pravastatin—atherosclerosis	0.000562	0.0022	CcSEcCtD
Vinorelbine—Constipation—Pravastatin—atherosclerosis	0.000562	0.0022	CcSEcCtD
Vinorelbine—Hypersensitivity—Ezetimibe—atherosclerosis	0.000562	0.0022	CcSEcCtD
Vinorelbine—TUBB—adipose tissue—atherosclerosis	0.000561	0.0439	CbGeAlD
Vinorelbine—TUBB2A—adipose tissue—atherosclerosis	0.000558	0.0437	CbGeAlD
Vinorelbine—Asthenia—Lovastatin—atherosclerosis	0.000558	0.00218	CcSEcCtD
Vinorelbine—TUBB6—adipose tissue—atherosclerosis	0.000551	0.0431	CbGeAlD
Vinorelbine—Pruritus—Lovastatin—atherosclerosis	0.00055	0.00215	CcSEcCtD
Vinorelbine—Asthenia—Ezetimibe—atherosclerosis	0.000547	0.00214	CcSEcCtD
Vinorelbine—Gastrointestinal pain—Niacin—atherosclerosis	0.000546	0.00214	CcSEcCtD
Vinorelbine—Nausea—Rosuvastatin—atherosclerosis	0.000545	0.00213	CcSEcCtD
Vinorelbine—TUBB4B—cardiovascular system—atherosclerosis	0.000543	0.0424	CbGeAlD
Vinorelbine—Feeling abnormal—Pravastatin—atherosclerosis	0.000542	0.00212	CcSEcCtD
Vinorelbine—Pruritus—Ezetimibe—atherosclerosis	0.000539	0.00211	CcSEcCtD
Vinorelbine—Gastrointestinal pain—Pravastatin—atherosclerosis	0.000537	0.0021	CcSEcCtD
Vinorelbine—Hypersensitivity—Simvastatin—atherosclerosis	0.000536	0.0021	CcSEcCtD
Vinorelbine—Diarrhoea—Lovastatin—atherosclerosis	0.000532	0.00208	CcSEcCtD
Vinorelbine—Urticaria—Niacin—atherosclerosis	0.00053	0.00208	CcSEcCtD
Vinorelbine—Abdominal pain—Niacin—atherosclerosis	0.000528	0.00207	CcSEcCtD
Vinorelbine—Body temperature increased—Niacin—atherosclerosis	0.000528	0.00207	CcSEcCtD
Vinorelbine—Urticaria—Pravastatin—atherosclerosis	0.000522	0.00204	CcSEcCtD
Vinorelbine—Asthenia—Simvastatin—atherosclerosis	0.000522	0.00204	CcSEcCtD
Vinorelbine—Diarrhoea—Ezetimibe—atherosclerosis	0.000522	0.00204	CcSEcCtD
Vinorelbine—Abdominal pain—Pravastatin—atherosclerosis	0.00052	0.00203	CcSEcCtD
Vinorelbine—Body temperature increased—Pravastatin—atherosclerosis	0.00052	0.00203	CcSEcCtD
Vinorelbine—Pruritus—Simvastatin—atherosclerosis	0.000514	0.00201	CcSEcCtD
Vinorelbine—Dizziness—Lovastatin—atherosclerosis	0.000514	0.00201	CcSEcCtD
Vinorelbine—Dizziness—Ezetimibe—atherosclerosis	0.000504	0.00197	CcSEcCtD
Vinorelbine—Diarrhoea—Simvastatin—atherosclerosis	0.000497	0.00195	CcSEcCtD
Vinorelbine—Vomiting—Lovastatin—atherosclerosis	0.000494	0.00193	CcSEcCtD
Vinorelbine—Hypersensitivity—Niacin—atherosclerosis	0.000492	0.00193	CcSEcCtD
Vinorelbine—Rash—Lovastatin—atherosclerosis	0.00049	0.00192	CcSEcCtD
Vinorelbine—Dermatitis—Lovastatin—atherosclerosis	0.00049	0.00192	CcSEcCtD
Vinorelbine—Headache—Lovastatin—atherosclerosis	0.000487	0.00191	CcSEcCtD
Vinorelbine—Vomiting—Ezetimibe—atherosclerosis	0.000485	0.0019	CcSEcCtD
Vinorelbine—Hypersensitivity—Pravastatin—atherosclerosis	0.000484	0.0019	CcSEcCtD
Vinorelbine—Dizziness—Simvastatin—atherosclerosis	0.000481	0.00188	CcSEcCtD
Vinorelbine—Rash—Ezetimibe—atherosclerosis	0.000481	0.00188	CcSEcCtD
Vinorelbine—Dermatitis—Ezetimibe—atherosclerosis	0.00048	0.00188	CcSEcCtD
Vinorelbine—Asthenia—Niacin—atherosclerosis	0.000479	0.00188	CcSEcCtD
Vinorelbine—TUBB4B—adipose tissue—atherosclerosis	0.000479	0.0374	CbGeAlD
Vinorelbine—Headache—Ezetimibe—atherosclerosis	0.000478	0.00187	CcSEcCtD
Vinorelbine—Pruritus—Niacin—atherosclerosis	0.000472	0.00185	CcSEcCtD
Vinorelbine—Asthenia—Pravastatin—atherosclerosis	0.000472	0.00185	CcSEcCtD
Vinorelbine—Pruritus—Pravastatin—atherosclerosis	0.000465	0.00182	CcSEcCtD
Vinorelbine—Vomiting—Simvastatin—atherosclerosis	0.000462	0.00181	CcSEcCtD
Vinorelbine—Nausea—Lovastatin—atherosclerosis	0.000462	0.00181	CcSEcCtD
Vinorelbine—Rash—Simvastatin—atherosclerosis	0.000458	0.00179	CcSEcCtD
Vinorelbine—Dermatitis—Simvastatin—atherosclerosis	0.000458	0.00179	CcSEcCtD
Vinorelbine—Diarrhoea—Niacin—atherosclerosis	0.000457	0.00179	CcSEcCtD
Vinorelbine—Headache—Simvastatin—atherosclerosis	0.000455	0.00178	CcSEcCtD
Vinorelbine—Nausea—Ezetimibe—atherosclerosis	0.000453	0.00177	CcSEcCtD
Vinorelbine—Diarrhoea—Pravastatin—atherosclerosis	0.00045	0.00176	CcSEcCtD
Vinorelbine—Dizziness—Niacin—atherosclerosis	0.000441	0.00173	CcSEcCtD
Vinorelbine—Dizziness—Pravastatin—atherosclerosis	0.000435	0.0017	CcSEcCtD
Vinorelbine—Nausea—Simvastatin—atherosclerosis	0.000432	0.00169	CcSEcCtD
Vinorelbine—TUBB4A—liver—atherosclerosis	0.00043	0.0336	CbGeAlD
Vinorelbine—Vomiting—Niacin—atherosclerosis	0.000424	0.00166	CcSEcCtD
Vinorelbine—Rash—Niacin—atherosclerosis	0.000421	0.00165	CcSEcCtD
Vinorelbine—Dermatitis—Niacin—atherosclerosis	0.000421	0.00165	CcSEcCtD
Vinorelbine—Headache—Niacin—atherosclerosis	0.000418	0.00164	CcSEcCtD
Vinorelbine—Vomiting—Pravastatin—atherosclerosis	0.000418	0.00164	CcSEcCtD
Vinorelbine—Rash—Pravastatin—atherosclerosis	0.000414	0.00162	CcSEcCtD
Vinorelbine—Dermatitis—Pravastatin—atherosclerosis	0.000414	0.00162	CcSEcCtD
Vinorelbine—Headache—Pravastatin—atherosclerosis	0.000412	0.00161	CcSEcCtD
Vinorelbine—Nausea—Niacin—atherosclerosis	0.000397	0.00155	CcSEcCtD
Vinorelbine—TUBB—liver—atherosclerosis	0.000394	0.0308	CbGeAlD
Vinorelbine—TUBB2A—liver—atherosclerosis	0.000392	0.0306	CbGeAlD
Vinorelbine—Nausea—Pravastatin—atherosclerosis	0.00039	0.00153	CcSEcCtD
Vinorelbine—TUBB6—liver—atherosclerosis	0.000386	0.0302	CbGeAlD
Vinorelbine—ABCB1—blood vessel—atherosclerosis	0.000354	0.0277	CbGeAlD
Vinorelbine—TUBB4B—liver—atherosclerosis	0.000336	0.0262	CbGeAlD
Vinorelbine—ABCB1—cardiovascular system—atherosclerosis	0.000158	0.0123	CbGeAlD
Vinorelbine—ABCB1—adipose tissue—atherosclerosis	0.000139	0.0109	CbGeAlD
Vinorelbine—CYP3A4—liver—atherosclerosis	0.000138	0.0108	CbGeAlD
Vinorelbine—CYP2D6—liver—atherosclerosis	0.000136	0.0106	CbGeAlD
Vinorelbine—ABCB1—liver—atherosclerosis	9.76e-05	0.00763	CbGeAlD
Vinorelbine—TUBB2A—Metabolism of proteins—MMP1—atherosclerosis	7.56e-05	0.000759	CbGpPWpGaD
Vinorelbine—TUBB4B—Metabolism of proteins—IGF2—atherosclerosis	7.56e-05	0.000759	CbGpPWpGaD
Vinorelbine—TUBB3—Metabolism of proteins—LEP—atherosclerosis	7.56e-05	0.000759	CbGpPWpGaD
Vinorelbine—TUBB2A—Metabolism of proteins—AGT—atherosclerosis	7.47e-05	0.00075	CbGpPWpGaD
Vinorelbine—TUBB4A—Transmembrane transport of small molecules—PPARA—atherosclerosis	7.45e-05	0.000748	CbGpPWpGaD
Vinorelbine—TUBB1—Metabolism of proteins—MMP1—atherosclerosis	7.39e-05	0.000742	CbGpPWpGaD
Vinorelbine—TUBB6—Metabolism of proteins—F2—atherosclerosis	7.38e-05	0.000741	CbGpPWpGaD
Vinorelbine—TUBB2B—Metabolism of proteins—F2—atherosclerosis	7.38e-05	0.000741	CbGpPWpGaD
Vinorelbine—TUBB2A—Metabolism of proteins—LEP—atherosclerosis	7.32e-05	0.000735	CbGpPWpGaD
Vinorelbine—TUBB1—Metabolism of proteins—AGT—atherosclerosis	7.3e-05	0.000733	CbGpPWpGaD
Vinorelbine—ABCB1—Allograft Rejection—IFNG—atherosclerosis	7.17e-05	0.00072	CbGpPWpGaD
Vinorelbine—TUBB1—Metabolism of proteins—LEP—atherosclerosis	7.15e-05	0.000718	CbGpPWpGaD
Vinorelbine—TUBB3—Metabolism of proteins—F2—atherosclerosis	7.12e-05	0.000715	CbGpPWpGaD
Vinorelbine—TUBB4A—Transmembrane transport of small molecules—APOA1—atherosclerosis	6.99e-05	0.000702	CbGpPWpGaD
Vinorelbine—TUBB2A—Metabolism of proteins—F2—atherosclerosis	6.9e-05	0.000693	CbGpPWpGaD
Vinorelbine—TUBB4B—Transmembrane transport of small molecules—PPARA—atherosclerosis	6.81e-05	0.000684	CbGpPWpGaD
Vinorelbine—TUBB1—Metabolism of proteins—F2—atherosclerosis	6.75e-05	0.000677	CbGpPWpGaD
Vinorelbine—TUBB6—Transmembrane transport of small molecules—ALB—atherosclerosis	6.74e-05	0.000677	CbGpPWpGaD
Vinorelbine—TUBB2B—Transmembrane transport of small molecules—ALB—atherosclerosis	6.74e-05	0.000677	CbGpPWpGaD
Vinorelbine—TUBB2B—Metabolism of proteins—INS—atherosclerosis	6.68e-05	0.000671	CbGpPWpGaD
Vinorelbine—TUBB6—Metabolism of proteins—INS—atherosclerosis	6.68e-05	0.000671	CbGpPWpGaD
Vinorelbine—ABCB1—Allograft Rejection—CXCL8—atherosclerosis	6.66e-05	0.000669	CbGpPWpGaD
Vinorelbine—TUBB4A—Metabolism of proteins—MMP1—atherosclerosis	6.64e-05	0.000667	CbGpPWpGaD
Vinorelbine—TUBB6—Metabolism of proteins—CCL2—atherosclerosis	6.58e-05	0.00066	CbGpPWpGaD
Vinorelbine—TUBB2B—Metabolism of proteins—CCL2—atherosclerosis	6.58e-05	0.00066	CbGpPWpGaD
Vinorelbine—TUBB4A—Metabolism of proteins—AGT—atherosclerosis	6.56e-05	0.000658	CbGpPWpGaD
Vinorelbine—TUBB3—Transmembrane transport of small molecules—ALB—atherosclerosis	6.51e-05	0.000654	CbGpPWpGaD
Vinorelbine—TUBB2B—Metabolism of proteins—IGF1—atherosclerosis	6.46e-05	0.000649	CbGpPWpGaD
Vinorelbine—TUBB6—Metabolism of proteins—IGF1—atherosclerosis	6.46e-05	0.000649	CbGpPWpGaD
Vinorelbine—TUBB3—Metabolism of proteins—INS—atherosclerosis	6.45e-05	0.000648	CbGpPWpGaD
Vinorelbine—TUBB4A—Metabolism of proteins—LEP—atherosclerosis	6.42e-05	0.000645	CbGpPWpGaD
Vinorelbine—ABCB1—Allograft Rejection—IL1B—atherosclerosis	6.39e-05	0.000642	CbGpPWpGaD
Vinorelbine—TUBB4B—Transmembrane transport of small molecules—APOA1—atherosclerosis	6.39e-05	0.000642	CbGpPWpGaD
Vinorelbine—ABCB1—Transmembrane transport of small molecules—ABCG1—atherosclerosis	6.38e-05	0.000641	CbGpPWpGaD
Vinorelbine—TUBB3—Metabolism of proteins—CCL2—atherosclerosis	6.35e-05	0.000638	CbGpPWpGaD
Vinorelbine—TUBB2A—Transmembrane transport of small molecules—ALB—atherosclerosis	6.31e-05	0.000633	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—SIRT1—atherosclerosis	6.27e-05	0.00063	CbGpPWpGaD
Vinorelbine—TUBB6—Metabolism of proteins—MMP2—atherosclerosis	6.26e-05	0.000628	CbGpPWpGaD
Vinorelbine—TUBB2B—Metabolism of proteins—MMP2—atherosclerosis	6.26e-05	0.000628	CbGpPWpGaD
Vinorelbine—TUBB2A—Metabolism of proteins—INS—atherosclerosis	6.25e-05	0.000628	CbGpPWpGaD
Vinorelbine—ABCB1—HIF-1-alpha transcription factor network—VEGFA—atherosclerosis	6.25e-05	0.000627	CbGpPWpGaD
Vinorelbine—TUBB3—Metabolism of proteins—IGF1—atherosclerosis	6.24e-05	0.000627	CbGpPWpGaD
Vinorelbine—TUBB1—Transmembrane transport of small molecules—ALB—atherosclerosis	6.17e-05	0.000619	CbGpPWpGaD
Vinorelbine—CYP2D6—Biological oxidations—GSTM1—atherosclerosis	6.16e-05	0.000619	CbGpPWpGaD
Vinorelbine—TUBB2A—Metabolism of proteins—CCL2—atherosclerosis	6.15e-05	0.000617	CbGpPWpGaD
Vinorelbine—TUBB1—Metabolism of proteins—INS—atherosclerosis	6.11e-05	0.000614	CbGpPWpGaD
Vinorelbine—CYP2D6—Metapathway biotransformation—GSTM1—atherosclerosis	6.08e-05	0.00061	CbGpPWpGaD
Vinorelbine—TUBB4B—Metabolism of proteins—MMP1—atherosclerosis	6.07e-05	0.00061	CbGpPWpGaD
Vinorelbine—TUBB4A—Metabolism of proteins—F2—atherosclerosis	6.06e-05	0.000608	CbGpPWpGaD
Vinorelbine—TUBB2A—Metabolism of proteins—IGF1—atherosclerosis	6.05e-05	0.000607	CbGpPWpGaD
Vinorelbine—TUBB3—Metabolism of proteins—MMP2—atherosclerosis	6.04e-05	0.000607	CbGpPWpGaD
Vinorelbine—TUBB1—Metabolism of proteins—CCL2—atherosclerosis	6.01e-05	0.000604	CbGpPWpGaD
Vinorelbine—TUBB4B—Metabolism of proteins—AGT—atherosclerosis	6e-05	0.000602	CbGpPWpGaD
Vinorelbine—TUBB1—Metabolism of proteins—IGF1—atherosclerosis	5.91e-05	0.000594	CbGpPWpGaD
Vinorelbine—TUBB4B—Metabolism of proteins—LEP—atherosclerosis	5.88e-05	0.00059	CbGpPWpGaD
Vinorelbine—TUBB2A—Metabolism of proteins—MMP2—atherosclerosis	5.85e-05	0.000587	CbGpPWpGaD
Vinorelbine—ABCB1—Transmembrane transport of small molecules—CYP7A1—atherosclerosis	5.78e-05	0.000581	CbGpPWpGaD
Vinorelbine—TUBB1—Metabolism of proteins—MMP2—atherosclerosis	5.72e-05	0.000574	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—atherosclerosis	5.59e-05	0.000561	CbGpPWpGaD
Vinorelbine—TUBB4B—Metabolism of proteins—F2—atherosclerosis	5.54e-05	0.000556	CbGpPWpGaD
Vinorelbine—TUBB4A—Transmembrane transport of small molecules—ALB—atherosclerosis	5.54e-05	0.000556	CbGpPWpGaD
Vinorelbine—TUBB4A—Metabolism of proteins—INS—atherosclerosis	5.49e-05	0.000551	CbGpPWpGaD
Vinorelbine—ABCB1—Allograft Rejection—VEGFA—atherosclerosis	5.41e-05	0.000543	CbGpPWpGaD
Vinorelbine—TUBB4A—Metabolism of proteins—CCL2—atherosclerosis	5.4e-05	0.000542	CbGpPWpGaD
Vinorelbine—TUBB—Cell Cycle, Mitotic—MAPK3—atherosclerosis	5.31e-05	0.000533	CbGpPWpGaD
Vinorelbine—TUBB4A—Metabolism of proteins—IGF1—atherosclerosis	5.31e-05	0.000533	CbGpPWpGaD
Vinorelbine—ABCB1—Transmembrane transport of small molecules—TRPV1—atherosclerosis	5.2e-05	0.000522	CbGpPWpGaD
Vinorelbine—TUBB2B—Metabolism of proteins—CXCL8—atherosclerosis	5.2e-05	0.000522	CbGpPWpGaD
Vinorelbine—TUBB6—Metabolism of proteins—CXCL8—atherosclerosis	5.2e-05	0.000522	CbGpPWpGaD
Vinorelbine—TUBB4A—Metabolism of proteins—MMP2—atherosclerosis	5.14e-05	0.000516	CbGpPWpGaD
Vinorelbine—TUBB4B—Transmembrane transport of small molecules—ALB—atherosclerosis	5.06e-05	0.000508	CbGpPWpGaD
Vinorelbine—TUBB3—Metabolism of proteins—CXCL8—atherosclerosis	5.02e-05	0.000504	CbGpPWpGaD
Vinorelbine—TUBB4B—Metabolism of proteins—INS—atherosclerosis	5.02e-05	0.000504	CbGpPWpGaD
Vinorelbine—ABCB1—Transmembrane transport of small molecules—ABCG5—atherosclerosis	5.01e-05	0.000503	CbGpPWpGaD
Vinorelbine—ABCB1—Allograft Rejection—TGFB1—atherosclerosis	4.97e-05	0.000499	CbGpPWpGaD
Vinorelbine—TUBB4B—Metabolism of proteins—CCL2—atherosclerosis	4.94e-05	0.000496	CbGpPWpGaD
Vinorelbine—TUBB2A—Metabolism of proteins—CXCL8—atherosclerosis	4.86e-05	0.000488	CbGpPWpGaD
Vinorelbine—TUBB4B—Metabolism of proteins—IGF1—atherosclerosis	4.86e-05	0.000487	CbGpPWpGaD
Vinorelbine—TUBB1—Metabolism of proteins—CXCL8—atherosclerosis	4.75e-05	0.000477	CbGpPWpGaD
Vinorelbine—TUBB—Cell Cycle—MAPK3—atherosclerosis	4.75e-05	0.000477	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—atherosclerosis	4.72e-05	0.000474	CbGpPWpGaD
Vinorelbine—TUBB4B—Metabolism of proteins—MMP2—atherosclerosis	4.7e-05	0.000472	CbGpPWpGaD
Vinorelbine—ABCB1—Allograft Rejection—TNF—atherosclerosis	4.64e-05	0.000466	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—LDLRAP1—atherosclerosis	4.64e-05	0.000466	CbGpPWpGaD
Vinorelbine—TUBB4A—Cell Cycle, Mitotic—MAPK3—atherosclerosis	4.4e-05	0.000442	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—LDLRAP1—atherosclerosis	4.37e-05	0.000439	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—PLTP—atherosclerosis	4.36e-05	0.000438	CbGpPWpGaD
Vinorelbine—TUBB4A—Metabolism of proteins—CXCL8—atherosclerosis	4.27e-05	0.000429	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—PLTP—atherosclerosis	4.11e-05	0.000412	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—atherosclerosis	4.09e-05	0.000411	CbGpPWpGaD
Vinorelbine—CYP3A4—Biological oxidations—GSTM1—atherosclerosis	4.03e-05	0.000405	CbGpPWpGaD
Vinorelbine—TUBB4B—Cell Cycle, Mitotic—MAPK3—atherosclerosis	4.02e-05	0.000404	CbGpPWpGaD
Vinorelbine—ABCB1—HIF-1-alpha transcription factor network—AKT1—atherosclerosis	3.99e-05	0.0004	CbGpPWpGaD
Vinorelbine—CYP3A4—Metapathway biotransformation—GSTM1—atherosclerosis	3.97e-05	0.000399	CbGpPWpGaD
Vinorelbine—TUBB4A—Cell Cycle—MAPK3—atherosclerosis	3.93e-05	0.000395	CbGpPWpGaD
Vinorelbine—TUBB4B—Metabolism of proteins—CXCL8—atherosclerosis	3.9e-05	0.000392	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—ABCG8—atherosclerosis	3.78e-05	0.00038	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—LTA4H—atherosclerosis	3.78e-05	0.00038	CbGpPWpGaD
Vinorelbine—ABCB1—Transmembrane transport of small molecules—CETP—atherosclerosis	3.71e-05	0.000372	CbGpPWpGaD
Vinorelbine—TUBB4B—Cell Cycle—MAPK3—atherosclerosis	3.6e-05	0.000361	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—ABCG8—atherosclerosis	3.56e-05	0.000358	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—LTA4H—atherosclerosis	3.56e-05	0.000358	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—atherosclerosis	3.39e-05	0.00034	CbGpPWpGaD
Vinorelbine—ABCB1—Transmembrane transport of small molecules—PLAT—atherosclerosis	3.27e-05	0.000328	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—ABCG1—atherosclerosis	2.99e-05	0.0003	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—atherosclerosis	2.94e-05	0.000295	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—atherosclerosis	2.89e-05	0.00029	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—LDLRAP1—atherosclerosis	2.86e-05	0.000287	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—ABCG1—atherosclerosis	2.82e-05	0.000283	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—LCAT—atherosclerosis	2.81e-05	0.000282	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—FABP4—atherosclerosis	2.81e-05	0.000282	CbGpPWpGaD
Vinorelbine—ABCB1—Transmembrane transport of small molecules—PLG—atherosclerosis	2.78e-05	0.000279	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—APOA4—atherosclerosis	2.76e-05	0.000277	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—CYP7A1—atherosclerosis	2.71e-05	0.000272	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—PLTP—atherosclerosis	2.69e-05	0.00027	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—atherosclerosis	2.67e-05	0.000268	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—FABP4—atherosclerosis	2.65e-05	0.000266	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—LCAT—atherosclerosis	2.65e-05	0.000266	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—APOA4—atherosclerosis	2.6e-05	0.000261	CbGpPWpGaD
Vinorelbine—ABCB1—Transmembrane transport of small molecules—HMOX1—atherosclerosis	2.56e-05	0.000257	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—CYP7A1—atherosclerosis	2.55e-05	0.000256	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—atherosclerosis	2.53e-05	0.000254	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—CYP27A1—atherosclerosis	2.5e-05	0.000251	CbGpPWpGaD
Vinorelbine—ABCB1—Transmembrane transport of small molecules—APOB—atherosclerosis	2.45e-05	0.000246	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—atherosclerosis	2.45e-05	0.000246	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—ALOX5AP—atherosclerosis	2.37e-05	0.000238	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—APOA2—atherosclerosis	2.37e-05	0.000238	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—ALOX15—atherosclerosis	2.37e-05	0.000238	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—PLA2G2A—atherosclerosis	2.37e-05	0.000238	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—CYP27A1—atherosclerosis	2.36e-05	0.000237	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—ABCG5—atherosclerosis	2.34e-05	0.000235	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—LTA4H—atherosclerosis	2.33e-05	0.000234	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—ABCG8—atherosclerosis	2.33e-05	0.000234	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—atherosclerosis	2.29e-05	0.00023	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—LPA—atherosclerosis	2.26e-05	0.000227	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—APOA2—atherosclerosis	2.24e-05	0.000225	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—ALOX5AP—atherosclerosis	2.24e-05	0.000225	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—PLA2G2A—atherosclerosis	2.24e-05	0.000225	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—ALOX15—atherosclerosis	2.24e-05	0.000225	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—ABCG5—atherosclerosis	2.21e-05	0.000222	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—BGN—atherosclerosis	2.19e-05	0.00022	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—APOA5—atherosclerosis	2.17e-05	0.000218	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—LPA—atherosclerosis	2.13e-05	0.000214	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—PLA2G1B—atherosclerosis	2.09e-05	0.00021	CbGpPWpGaD
Vinorelbine—ABCB1—Transmembrane transport of small molecules—PPARA—atherosclerosis	2.07e-05	0.000208	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—BGN—atherosclerosis	2.07e-05	0.000208	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—APOA5—atherosclerosis	2.05e-05	0.000205	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—ALOX5—atherosclerosis	2.02e-05	0.000203	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—PLA2G1B—atherosclerosis	1.97e-05	0.000198	CbGpPWpGaD
Vinorelbine—ABCB1—Transmembrane transport of small molecules—APOA1—atherosclerosis	1.94e-05	0.000195	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—ALOX5—atherosclerosis	1.9e-05	0.000191	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—ABCG1—atherosclerosis	1.84e-05	0.000185	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—NAMPT—atherosclerosis	1.81e-05	0.000182	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—LIPC—atherosclerosis	1.8e-05	0.000181	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—APOC3—atherosclerosis	1.79e-05	0.00018	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—LDLR—atherosclerosis	1.78e-05	0.000178	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—CETP—atherosclerosis	1.74e-05	0.000174	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—FABP4—atherosclerosis	1.73e-05	0.000174	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—LCAT—atherosclerosis	1.73e-05	0.000174	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—NAMPT—atherosclerosis	1.71e-05	0.000171	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—atherosclerosis	1.7e-05	0.000171	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—APOA4—atherosclerosis	1.7e-05	0.000171	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—LIPC—atherosclerosis	1.7e-05	0.00017	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—APOC3—atherosclerosis	1.68e-05	0.000169	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—LDLR—atherosclerosis	1.67e-05	0.000168	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—CYP7A1—atherosclerosis	1.67e-05	0.000168	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—SCARB1—atherosclerosis	1.66e-05	0.000167	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—CETP—atherosclerosis	1.64e-05	0.000164	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—HMGCR—atherosclerosis	1.57e-05	0.000158	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—SCARB1—atherosclerosis	1.57e-05	0.000157	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—CYP27A1—atherosclerosis	1.54e-05	0.000155	CbGpPWpGaD
Vinorelbine—ABCB1—Transmembrane transport of small molecules—ALB—atherosclerosis	1.54e-05	0.000154	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—HMGCR—atherosclerosis	1.48e-05	0.000149	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—ALOX5AP—atherosclerosis	1.46e-05	0.000147	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—PLA2G2A—atherosclerosis	1.46e-05	0.000147	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—ALOX15—atherosclerosis	1.46e-05	0.000147	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—APOA2—atherosclerosis	1.46e-05	0.000147	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—ABCG5—atherosclerosis	1.44e-05	0.000145	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—ABCA1—atherosclerosis	1.4e-05	0.00014	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—LPA—atherosclerosis	1.4e-05	0.00014	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—BGN—atherosclerosis	1.35e-05	0.000136	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—APOA5—atherosclerosis	1.34e-05	0.000134	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—ABCA1—atherosclerosis	1.32e-05	0.000132	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—PLA2G1B—atherosclerosis	1.29e-05	0.000129	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—ALOX5—atherosclerosis	1.24e-05	0.000125	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—HMOX1—atherosclerosis	1.2e-05	0.000121	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—APOB—atherosclerosis	1.15e-05	0.000115	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—HMOX1—atherosclerosis	1.13e-05	0.000114	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—GSTM1—atherosclerosis	1.12e-05	0.000112	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—NAMPT—atherosclerosis	1.12e-05	0.000112	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—LIPC—atherosclerosis	1.11e-05	0.000111	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—APOC3—atherosclerosis	1.1e-05	0.000111	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—LPL—atherosclerosis	1.1e-05	0.00011	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—LDLR—atherosclerosis	1.09e-05	0.00011	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—APOB—atherosclerosis	1.08e-05	0.000109	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—GPX1—atherosclerosis	1.07e-05	0.000108	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—CETP—atherosclerosis	1.07e-05	0.000107	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—GSTM1—atherosclerosis	1.05e-05	0.000106	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—CD36—atherosclerosis	1.04e-05	0.000105	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—LPL—atherosclerosis	1.03e-05	0.000104	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—SCARB1—atherosclerosis	1.02e-05	0.000103	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—GPX1—atherosclerosis	1.01e-05	0.000101	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—MTHFR—atherosclerosis	9.88e-06	9.92e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—CD36—atherosclerosis	9.83e-06	9.87e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—PPARA—atherosclerosis	9.7e-06	9.74e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—HMGCR—atherosclerosis	9.67e-06	9.71e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—AGT—atherosclerosis	9.39e-06	9.43e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—MTHFR—atherosclerosis	9.31e-06	9.35e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—APOE—atherosclerosis	9.2e-06	9.24e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—PPARA—atherosclerosis	9.14e-06	9.17e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—CAV1—atherosclerosis	9.12e-06	9.15e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—APOA1—atherosclerosis	9.1e-06	9.13e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—AGT—atherosclerosis	8.85e-06	8.89e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—APOE—atherosclerosis	8.67e-06	8.71e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—ABCA1—atherosclerosis	8.62e-06	8.65e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—CAV1—atherosclerosis	8.59e-06	8.63e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—APOA1—atherosclerosis	8.57e-06	8.61e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—PIK3CG—atherosclerosis	8.3e-06	8.34e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—PPARG—atherosclerosis	8.02e-06	8.05e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—INS—atherosclerosis	7.86e-06	7.89e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—PIK3CG—atherosclerosis	7.83e-06	7.86e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—PPARG—atherosclerosis	7.55e-06	7.58e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—INS—atherosclerosis	7.41e-06	7.44e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—HMOX1—atherosclerosis	7.4e-06	7.42e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—ALB—atherosclerosis	7.21e-06	7.24e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—APOB—atherosclerosis	7.08e-06	7.11e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—NOS3—atherosclerosis	6.89e-06	6.92e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—GSTM1—atherosclerosis	6.89e-06	6.92e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—ALB—atherosclerosis	6.79e-06	6.82e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—LPL—atherosclerosis	6.76e-06	6.79e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—GPX1—atherosclerosis	6.6e-06	6.63e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—NOS3—atherosclerosis	6.5e-06	6.52e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—CD36—atherosclerosis	6.43e-06	6.45e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—PTGS2—atherosclerosis	6.31e-06	6.33e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—MTHFR—atherosclerosis	6.09e-06	6.11e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—PPARA—atherosclerosis	5.97e-06	6e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—PTGS2—atherosclerosis	5.94e-06	5.97e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—AGT—atherosclerosis	5.79e-06	5.81e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—APOE—atherosclerosis	5.67e-06	5.69e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—CAV1—atherosclerosis	5.62e-06	5.64e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—APOA1—atherosclerosis	5.6e-06	5.63e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—PIK3CG—atherosclerosis	5.12e-06	5.14e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—PPARG—atherosclerosis	4.94e-06	4.96e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—INS—atherosclerosis	4.84e-06	4.86e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—ALB—atherosclerosis	4.44e-06	4.46e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—NOS3—atherosclerosis	4.25e-06	4.26e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—PTGS2—atherosclerosis	3.88e-06	3.9e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—AKT1—atherosclerosis	3.17e-06	3.18e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—AKT1—atherosclerosis	2.99e-06	3e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—AKT1—atherosclerosis	1.95e-06	1.96e-05	CbGpPWpGaD
